Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

Fig. 3

Cell viability of MHCC97H (A) and HepG2 (B) after incubation with different concentrations of HMSNs and PLTM-HMSNs for 24 h. (C) The liver and kidney function indexes of BALB/c mice. All results are presented as the mean ± SD. (D) HE-stained organs from tumor-free BALB/c mice after injected with nanoparticles. Scale bar, 20 μm

Back to article page